Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Pinealoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Meningioma 1Medulloblastoma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ependymoma 1Craniopharyngioma 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 9Magnetic Resonance Spectroscopy 9Bevacizumab 8Radiotherapy 4Radiation 4Lomustine 3Carmustine 3pembrolizumab 2dexamethasone acetate 2atezolizumab 2TIC10 compound 2Surgical Procedures, Operative 2Sunitinib 2Standard of Care 2Specimen Handling 2Sorafenib 2Radiosurgery 2Irinotecan 2Dexamethasone 2Carboplatin 2Calcium Dobesilate 2Axitinib 2Aminolevulinic Acid 2vocimagene amiretrorepvec 1tandutinib 1poly ICLC 1pazopanib 1niraparib 1keyhole-limpet hemocyanin 1gallium Ga 68 dotatate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Glioblastoma × Gadolinium DTPA × Clear all
NCT00005790 2012-06-11

Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors

Northwestern University

Phase NA Withdrawn
CNSSarcoma

Astrocytoma, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡